Myelodysplastic syndromes D46

  • D46 should not be used for reimbursement purposes. Please select a more specific diagnosis below.
  • The 2019 edition of ICD-10-CM D46 became effective on October 1, 2018.
  • This is the American ICD-10-CM version of D46 - other international versions of ICD-10 D46 may differ.
Use Additional:
  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Type 2 Excludes:
  • drug-induced aplastic anemia (D61.1)

Codes: = Billable

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.